date:Apr 04, 2019
ement with private equity firm C2 Capital Partners for a share placement of A$0.65 per share. This will help the infant formula maker to raise approximately A$31.44million, before costs.
After the placement, C2 will buy additional shares in Bubs via off-market acquisitions from existing shareholders, theNuLac Foods Vendors. This will give C2 an aggregate 15% holding in Bubs.
With the capital investment, C2 managing partner Steve Lin will join the Bubs board as a non-executive director.
It pla